23andMe founder buys back genetic testing company ... Financial Times

23andMe founder buys back genetic testing company in second auction

Financial Times June 13, 2025
Upvote 0 Downvote

Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals

Read Full Article

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Related News
Source Information
Financial Times

Published on June 13, 2025

Visit Source
Advertise with Us

Reach our audience with your ads